CES1 and breast cancer: Antalis et al. [23] found that estrogen receptor negative (ER(−)) breast cancer cells had higher expression of ACAT1 as compared to ER(+)breast cancer cells, and proliferation of ER(−)breast cancer cells was reduced by inhibition of ACAT.